<code id='180788321E'></code><style id='180788321E'></style>
    • <acronym id='180788321E'></acronym>
      <center id='180788321E'><center id='180788321E'><tfoot id='180788321E'></tfoot></center><abbr id='180788321E'><dir id='180788321E'><tfoot id='180788321E'></tfoot><noframes id='180788321E'>

    • <optgroup id='180788321E'><strike id='180788321E'><sup id='180788321E'></sup></strike><code id='180788321E'></code></optgroup>
        1. <b id='180788321E'><label id='180788321E'><select id='180788321E'><dt id='180788321E'><span id='180788321E'></span></dt></select></label></b><u id='180788321E'></u>
          <i id='180788321E'><strike id='180788321E'><tt id='180788321E'><pre id='180788321E'></pre></tt></strike></i>

          entertainment

          entertainment

          author:explore    Page View:86436
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M
          Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

          CytokineticsCEORobertBlumspokelastweekatatalkduringSTAT’sBreakthroughSummitWestinSanFrancisco.SarahG

          read more
          Continuity nursing helped my family in our darkest PICU moments
          Continuity nursing helped my family in our darkest PICU moments

          EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

          read more

          First Opinion Podcast: Long Covid needs a new approach

          Sincetheearlydaysofthepandemic,longCovidhashauntedus:Evenamildacuteinfectionmightleaveyouwithlife-al